Literature DB >> 28422627

Quality of Life Perspectives of People With Amyotrophic Lateral Sclerosis and Their Caregivers.

Stephanie Johnson1, Bryant Alonso2, Katie Faulkner3, Haley Roberts4, Britton Monroe5, Leigh Lehman6, Pamalyn Kearney7.   

Abstract

This study explored differences in perspectives on quality of life (QOL) between people affected by amyotrophic lateral sclerosis (ALS) and their caregivers. QOL is often thought of as related to physical limitations, without consideration of other factors (e.g., cognitive, emotional) that may be stronger predictors of QOL in people with long-term degenerative diseases. Because QOL is complex and influenced by multiple factors, people with ALS and their caregivers may have different perspectives on what constitutes QOL. This study investigated potential discrepancies in QOL perspectives between people with ALS and their caregivers. Thirty dyads from the Augusta University Health ALS Clinic completed a measure of QOL, and we compared the results and identified patterns. The most prominent finding was that members of the dyads misunderstood the mental experiences of one another.
Copyright © 2017 by the American Occupational Therapy Association, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28422627     DOI: 10.5014/ajot.2017.024828

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  2 in total

1.  Long-term outcomes after surgery to prevent aspiration for patients with amyotrophic lateral sclerosis.

Authors:  Temma Soga; Naoki Suzuki; Kengo Kato; Ai Kawamoto-Hirano; Yuko Kawauchi; Rumiko Izumi; Masaya Toyoshima; Shio Mitsuzawa; Tomomi Shijo; Kensuke Ikeda; Hitoshi Warita; Yukio Katori; Masashi Aoki; Masaaki Kato
Journal:  BMC Neurol       Date:  2022-03-16       Impact factor: 2.474

2.  Quality of life and mental health in the locked-in-state-differences between patients with amyotrophic lateral sclerosis and their next of kin.

Authors:  Elisa Aust; Katharina Linse; Sven-Thomas Graupner; Markus Joos; Daniel Liebscher; Julian Grosskreutz; Johannes Prudlo; Thomas Meyer; René Günther; Sebastian Pannasch; Andreas Hermann
Journal:  J Neurol       Date:  2022-07-06       Impact factor: 6.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.